AgelessRx competes in the same buyer journey as a longevity clinic but uses a treatment-by-treatment telehealth model. The low advertised entry prices are not a clinic membership. They are subscription prices attached to specific products after clinician review.
The evidence question is especially important because several offerings involve off-label use. Off-label prescribing can be medically appropriate. It does not mean the FDA evaluated that use or that a drug has been shown to extend lifespan in healthy people. Each product needs its own indication, monitoring plan, and risk discussion.
Core Services
- Low-dose naltrexone from $25 per month
- Metformin from $25 per month
- Rapamycin from $65 per month on the page reviewed
- Treatment-specific telehealth evaluation
- Pharmacy fulfillment and monitoring
Evidence Notes
A legal prescription and an FDA-approved drug do not prove a longevity benefit for an off-label use. Evidence varies by drug, indication, dose, population, and outcome. Rapamycin and metformin have serious research interest, but neither is approved as a treatment to extend human lifespan.
Questions to Ask
- What exact diagnosis or indication supports the prescription?
- What human outcome evidence supports this use?
- Which baseline and follow-up labs are required?
- Who manages interactions with my existing medications?
- How are side effects and discontinuation handled?